← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Novonesis 
Healthcare & biotech / Biotechnology, Enzymes, Sustainable Solutions
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCash Flow Statement
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Net Income | Depreciation And Amortization | Deferred Income Tax | Stock Based Compensation | Change In Working Capital | Accounts Receivables | Inventory | Accounts Payables | Other Working Capital | Other Non Cash Items | Net Cash Provided By Operating Activities | Investments In Property Plant And Equipment | Acquisitions Net | Purchases Of Investments | Sales Maturities Of Investments | Other Investing Activities | Net Cash Used For Investing Activities | Debt Repayment | Common Stock Issued | Common Stock Repurchased | Dividends Paid | Other Financing Activities | Net Cash Used Provided By Financing Activities | Effect Of Forex Changes On Cash | Net Change In Cash | Cash At End Of Period | Cash At Beginning Of Period | Operating Cash Flow | Capital Expenditure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12 | 305.8 | 0.0 | 0.0 | 0.0 | 271.0 | 0.0 | 0.0 | 0.0 | 271.0 | 443.1 | 1019.9 | -338.3 | 159.3 | 0.0 | 0.0 | -20.7 | -199.7 | -405.3 | 37.79 | 0.0 | -249.8 | -85.9 | -703.2 | 13.3 | 130.3 | 280.0 | 149.69 | 1019.9 | -359.8 |
| 2023-12 | 3024.0 | 1389.0 | 0.0 | 20.28 | -166.0 | -177.0 | 138.0 | 177.0 | -304.0 | -115.28 | 4152.0 | -1857.0 | -81.0 | 0.0 | 0.0 | -195.0 | -2133.0 | 865.0 | 22.4 | 0.0 | -2856.0 | 79.59 | -1889.0 | -55.0 | 75.0 | 1116.0 | 1041.0 | 4152.0 | -2056.0 |
| 2022-12 | 3686.0 | 1457.0 | 0.0 | 127.0 | -583.0 | -330.0 | -787.0 | 534.0 | -9.0 | -681.0 | 4006.0 | -2890.0 | 190.0 | 0.0 | 0.0 | 28.0 | -2672.0 | 418.0 | 164.0 | -500.0 | -1524.0 | 193.0 | -1250.0 | -6.0 | 78.0 | 1041.0 | 963.0 | 4006.0 | -2890.0 |
| 2021-12 | 3145.0 | 1416.0 | 1.0 | 78.0 | -612.0 | -574.0 | -556.0 | 518.0 | -8.0 | 34.0 | 4062.0 | -1240.0 | -1631.0 | 0.0 | 0.0 | 124.0 | -2747.0 | 758.0 | 309.0 | -1500.0 | -1465.0 | 313.0 | -1586.0 | 53.0 | -218.0 | 963.0 | 1181.0 | 4062.0 | -1240.0 |
Wait! There's more — sign up for free or log in